A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199

NCT03880487 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

26

Enrollment

INDUSTRY

Sponsor class

Stopped The Study was terminated early by sponsor

Conditions

Analgesia

Interventions

DRUG: KP-1199
DRUG: Placebo oral capsule
DRUG: Oxycodone oral capsule

Sponsor

Kalyra Pharmaceuticals, Inc.

Collaborators

[object Object]
[object Object]